Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants

Infection and Immunity

Volumn 83, Issue 6, 2015, Pages 2531-2541

  Lone, Abdul G ^a   Atci, Erhan ^b   Renslow, Ryan ^c   Beyenal, Haluk ^b   Noh, Susan ^a,d   Fransson, Boel ^a   Abu Lail, Nehal ^b   Park, Jeong Jin ^a   Gang, David R ^a   Call, Douglas R ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington State University   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DISSOLVED OXYGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; PROAPOPTOTIC PROGRAMMED CELL DEATH PROTEIN 5; UNCLASSIFIED DRUG; OXYGEN;

ALKALINITY; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOFILM; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; EXPLANT; HYPOXEMIA; MICROELECTRODE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TISSUE INJURY; ANIMAL; CULTURAL ANTHROPOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PH; PHYSIOLOGY; PIG; SKIN; TISSUE CULTURE TECHNIQUE;

ANIMALS; BIOFILMS; CULTURE; HYDROGEN-ION CONCENTRATION; OXYGEN; OXYGEN CONSUMPTION; SKIN; STAPHYLOCOCCUS AUREUS; SWINE; TISSUE CULTURE TECHNIQUES;

EID: 84929494264     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03075-14     Document Type: Article

References (77)

1. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568. http://dx.doi.org/10.1016/S0140-6736(09)61999-1.
2. Stryjewski ME, Corey GR. 2014. Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin Infect Dis 58(Suppl 1):S10-S19. http://dx.doi.org/10.1093/cid/cit613.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666-674. http://dx.doi.org/10.1056/NEJMoa055356.
4. O'Hara FP, Amrine-Madsen H, Mera RM, Brown ML, Close NM, Suaya JA, Acosta CJ. 2012. Molecular characterization of Staphylococcus aureus in the United States 2004-2008 reveals the rapid expansion of USA300 among inpatients and outpatients. Microb Drug Resist 18:555-561. http://dx.doi.org/10.1089/mdr.2012.0056.
5. James GA, Swogger E, Wolcott R, Pulcini ED, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wound Repair Regen 16:37-44. http://dx.doi.org/10.1111/j.1524-475X.2007.00321.x.
6. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD. 2008. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8:43. http://dx.doi.org/10.1186/1471-2180-8-43.
7. Kirketerp-Møller K, Zulkowski K, James G. 2011. Chronic wound colonization, infection, and biofilms, p 11-24. In Bjarnsholt T, Jensen P, Moser C, Hø iby N (ed), Biofilm infections. Springer, New York, NY.
8. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M. 2008. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16:2-10. http://dx.doi.org/10.1111/j.1524-475X.2007.00283.x.
9. Gordillo GM, Sen CK. 2003. Revisiting the essential role of oxygen in wound healing. Am J Surg 186:259-263. http://dx.doi.org/10.1016/S0002-9610(03)00211-3.
10. Tandara AA, Mustoe TA. 2004. Oxygen in wound healing-more than a nutrient. World J Surg 28:294-300. http://dx.doi.org/10.1007/s00268-003-7400-2.
11. Schneider LA, Korber A, Grabbe S, Dissemond J. 2007. Influence of pH on wound-healing: a new perspective for wound-therapy?. Arch Dermatol Res 298:413-420. http://dx.doi.org/10.1007/s00403-006-0713-x.
12. Sharpe JR, Booth S, Jubin K, Jordan NR, Lawrence-Watt DJ, Dheansa BS. 2013. Progression of wound pH during the course of healing in burns. J Burn Care Res 34:e201-e208. http://dx.doi.org/10.1097/BCR.0b013e31825d5569.
13. Behm B, Babilas P, Landthaler M, Schreml S. 2012. Cytokines, chemokines and growth factors in wound healing. J Eur Acad Dermatol Venereol 26:812-820. http://dx.doi.org/10.1111/j.1468-3083.2011.04415.x.
14. Parinello S. 2003. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5:839-839. http://dx.doi.org/10.1038/ncb1024.
15. LaVan FB, Hunt TK. 1990. Oxygen and wound healing. Clin Plast Surg 17:463-472.
16. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AAR, Anwar S, Willcocks LC, Whyte MKB, Condliffe AM, Chilvers ER. 2011. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. J Immunol 186:453-463. http://dx.doi.org/10.4049/jimmunol.1002213.
17. Gardner LB, Li F, Yang XJ, Dang CV. 2003. Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a. Mol Cell Biol 23:9032-9045. http://dx.doi.org/10.1128/MCB.23.24.9032-9045.2003.
18. Sen CK. 2009. Wound healing essentials: let there be oxygen. Wound Repair Regen 17:1-18. http://dx.doi.org/10.1111/j.1524-475X.2008.00436.x.
19. Schreml S, Szeimies RM, Karrer S, Heinlin J, Landthaler M, Babilas P. 2010. The impact of the pH value on skin integrity and cutaneous wound healing. J Eur Acad Dermatol Venereol 24:373-378. http://dx.doi.org/10.1111/j.1468-3083.2009.03413.x.
20. Gethin GT, Cowman S, Conroy RM. 2008. The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J 5:185-194. http://dx.doi.org/10.1111/j.1742-481X.2007.00424.x.
21. Sullivan TP, Eaglstein WH, Davis SC, Mertz P. 2001. The pig as a model for human wound healing. Wound Repair Regen 9:66-76. http://dx.doi.org/10.1046/j.1524-475x.2001.00066.x.
22. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. 2012. The pig: a model for human infectious diseases. Trends Microbiol 20:50-57. http://dx.doi.org/10.1016/j.tim.2011.11.002.
23. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 194:1761-1770. http://dx.doi.org/10.1086/509506.
24. Xiong YQ, Van Wamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS. 2002. Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis 186:668-677. http://dx.doi.org/10.1086/342046.
25. Renslow R, Babauta J, Majors P, Beyenal H. 2013. Diffusion in biofilms respiring on electrodes. Energy Environ Sci 6:595-607. http://dx.doi.org/10.1039/C2EE23394K.
26. Torrey HC. 1956. Bloch equations with diffusion terms. Phys Rev 104: 563-565. http://dx.doi.org/10.1103/PhysRev.104.563.
27. Renslow RS, Majors PD, McLean JS, Fredrickson JK, Ahmed B, Beyenal H. 2010. In situ effective diffusion coefficient profiles in live biofilms using pulsed-field gradient nuclear magnetic resonance. Biotechnol Bioeng 106: 928-937. http://dx.doi.org/10.1002/bit.22755.
28. Lewandowski Z, Beyenal H. 2013. Microsensors: construction, instrumentation, and calibration, p 269-351. In Lewandowski Z, Beyenal H (ed), Fundamentals of biofilm research, 2nd ed CRC Press.
29. Lewandowski Z, Beyenal H. 2013. Quantifying biofilm structure, p 353-436. In Lewandowski Z, BeyenalH(ed), Fundamentals of biofilm reseach, 2nd ed CRC Press, Boca Raton, FL.
30. Lewandowski Z, Beyenal H. 2003. Use of microsensors to study biofilms, p 375-412. In Lens P, O'Flaherty V, Moran A, Stoodley P, Mahony T (ed), Biofilms in medicine, industry and environmental biotechnology: characteristics, analysis and control. IWA Publishing, London, United Kingdom.
31. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. 2006. TM4 microarray software suite. Methods Enzymol 411:134-193. http://dx.doi.org/10.1016/S0076-6879(06)11009-5.
32. Carreau A, Hafny-Rahbi BE, Matejuk A, Grillon C, Kieda C. 2011. Why is the partial oxygen pressure of human tissues a crucial parameter?. Small molecules and hypoxia J Cell Mol Med 15:1239-1253. http://dx.doi.org/10.1111/j.1582-4934.2011.01258.x.
33. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537. http://dx.doi.org/10.1074/jbc.271.51.32529.
34. Kay HH, Zhu S, Tsoi S. 2007. Hypoxia and lactate production in trophoblast cells. Placenta 28:854-860. http://dx.doi.org/10.1016/j.placenta.2006.11.011.
35. Marti HH, Jung HH, Pfeilschifter J, Bauer C. 1994. Hypoxia and cobalt stimulate lactate dehydrogenase (LDH) activity in vascular smooth muscle cells. Pflugers Arch 429:216-222. http://dx.doi.org/10.1007/BF00374315.
36. Bender DA. 2009. Glycolysis and the oxidation of pyruvate, p 149-156. In Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA (ed), Harper's illustrated biochemistry, 28th ed. McGraw-Hill, New York, NY.
37. Hoffmann WE, Solter PF. 2008. Diagnostic enzymology of domestic animals, p 351-378. In Kaneko JJ, Harvey JW, Bruss ML (ed), Clinical biochemistry of domestic animals, 6th ed. Academic Press, New York, NY.
38. Co E, Keen EF, III, Aldous W. 2011. Prevalence of methicillin-resistant Staphylococcus aureus in a combat support hospital in Iraq. Mil Med 176: 89-93.
39. Keen EF, III, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, Murray CK. 2010. Incidence and bacteriology of burn infections at a military burn center. Burns 36:461-468. http://dx.doi.org/10.1016/j.burns.2009.10.012.
40. Smeltzer M, Beenken KE. 2013. Staphylococcus aureus, p 184-193. In McVey DS, Kennedy M, Chengappa MM (ed), Veterinary microbiology, 3rd ed. John Wiley & Sons, New York, NY.
41. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144:309-317. http://dx.doi.org/10.7326/0003-4819-144-5-200603070-00005.
42. Demling RH, Waterhouse B. 2007. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds 7:e8.
43. Hauck CR, Ohlsen K. 2006. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol 9:5-11. http://dx.doi.org/10.1016/j.mib.2005.12.002.
44. McGavin MH, Krajewska-Pietrasik D, Ryden C, Hook M. 1993. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun 61:2479-2485.
45. Howard MA, Asmis R, Evans KK, Mustoe TA. 2013. Oxygen and wound care: a review of current therapeutic modalities and future direction. Wound Repair Regen 21:503-511. http://dx.doi.org/10.1111/wrr.12069.
46. Kivisaari J, Vihersaari T, Renvall S, Niinikoski J. 1975. Energy metabolism of experimental wounds at various oxygen environments. Ann Surg 181:823. http://dx.doi.org/10.1097/00000658-197506000-00011.
47. Fuchs S, Pane-Farre J, Kohler C, Hecker M, Engelmann S. 2007. Anaerobic gene expression in Staphylococcus aureus. J Bacteriol 189:4275-4289. http://dx.doi.org/10.1128/JB.00081-07.
48. Richardson AR, Libby SJ, Fang FC. 2008. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319:1672-1676. http://dx.doi.org/10.1126/science.1155207.
49. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
50. Stewart KD, Brackett DJ, Lerner MR, Archer LT, Wilson MF. 1994. Comparison of Staphylococcus aureus and Escherichia coli infusion in conscious rats. J Surg Res 56:60-66. http://dx.doi.org/10.1006/jsre.1994.1010.
51. Meile L, Leisinger T. 1982. Purification and properties of the bifunctional proline dehydrogenase/1-pyrroline-5-carboxylate dehydrogenase from Pseudomonas aeruginosa. Eur J Biochem 129:67-75. http://dx.doi.org/10.1111/j.1432-1033.1982.tb07021.x.
52. Midelfort CF, Rose IA. 1977. Studies on the mechanism of Escherichia coli glucosamine-6-phosphate isomerase. Biochemistry 16:1590-1596. http://dx.doi.org/10.1021/bi00627a010.
53. Bellion E, Tan F. 1987. An NAD+-dependent alanine dehydrogenase from a methylotrophic bacterium. Biochem J 244:565-570.
54. Murray RK, Keeley FW. 2009. The extracellular matrix, p 527-544. In Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA (ed), Harper's illustrated biochemistry, 28th ed. McGraw-Hill, New York, NY.
55. Becker SA, Palsson BO. 2005. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the twodimensional annotation. BMC Microbiol 5:8. http://dx.doi.org/10.1186/1471-2180-5-8.
56. Thurlow LR, Joshi GS, Clark JR, Spontak JS, Neely CJ, Maile R, Richardson AR. 2013. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13:100-107. http://dx.doi.org/10.1016/j.chom.2012.11.012.
57. Kuroda M, Ohta T, Hayashi H. 1995. Isolation and the gene cloning of an alkaline shock protein in methicillin resistant Staphylococcus aureus. Biochem Biophys Res Commun 207:978-984. http://dx.doi.org/10.1006/bbrc.1995.1281.
58. Kohler T, Weidenmaier C, Peschel A. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J Bacteriol 191:4482-4484. http://dx.doi.org/10.1128/JB.00221-09.
59. Schmid-Wendtner M-H, Korting HC. 2006. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 19:296-302. http://dx.doi.org/10.1159/000094670.
60. Wang N, Lu HS, Guan ZP, Sun TZ, Chen YY, Ruan GR, Chen ZK, Jiang J, Bai CJ. 2007. Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis. Apoptosis 12:1433-1441. http://dx.doi.org/10.1007/s10495-007-0070-z.
61. Liu HT, Wang YG, Zhang YM, Song QS, Di CH, Chen GH, Tang J, Ma DL. 1999. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254:203-210. http://dx.doi.org/10.1006/bbrc.1998.9893.
62. Li HS, Zhang X, Song X, Zhu F, Wang Q, Guo C, Liu C, Shi Y, Ma C, Wang X. 2012. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway. Cancer Biol Ther 13:822-830. http://dx.doi.org/10.4161/cbt.20565.
63. Xu LJ, Hu J, Zhao YB, Hu J, Xiao J, Wang YM, Ma DL, Chen YY. 2012. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway. Apoptosis 17:1235-1245. http://dx.doi.org/10.1007/s10495-012-0754-x.
64. Xu LJ, Chen YY, Song QS, Xu D, Wang Y, Ma DL. 2009. PDCD5 interacts with tip60 and functions as a cooperator in acetyltransferase activity andDNAdamage-induced apoptosis. Neoplasia 11:345-354. http://dx.doi.org/10.1593/neo.81524.
65. Moll UM, Zaika A. 2001. Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493:65-69. http://dx.doi.org/10.1016/S0014-5793(01)02284-0.
66. Vousden KH, Lu X. 2002. Live or let die: the cell's response to p53. Nat Rev Cancer 2:594-604. http://dx.doi.org/10.1038/nrc864.
67. Tracy CM, Gray AJ, Cuéllar J, Shaw TS, Howlett AC, Taylor RM, Prince JT, Ahn NG, Valpuesta JM, Willardson BM. 2014. Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate β-tubulin folding. J Biol Chem 289:4490-4502. http://dx.doi.org/10.1074/jbc.M113.542159.
68. Alexander EH, Rivera FA, I M, Anguita J, Bost KL, Hudson MC. 2003. Staphylococcus aureus-induced tumor necrosis factor-related apoptosisinducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiol 3:5. http://dx.doi.org/10.1186/1471-2180-3-5.
69. Haslinger-Loffler B, Kahl BC, Grundmeier M, Strangfeld K, Wagner B, Fischer U, Cheung AL, Peters G, Schulze-Osthoff K, Sinha B. 2005. Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol 7:1087-1097. http://dx.doi.org/10.1111/j.1462-5822.2005.00533.x.
70. Hammond EM, Giaccia AJ. 2005. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331:718-725. http://dx.doi.org/10.1016/j.bbrc.2005.03.154.
71. Weinmann M, Jendrossek V, Handrick R, Guner D, Goecke B, Belka C. 2004. Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner. Oncogene 23:3757-3769. http://dx.doi.org/10.1038/sj.onc.1207481.
72. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-596. http://dx.doi.org/10.1038/nm1567.
73. Yonish-Rouach E, Resnftzky D, Lotem J, Sachs L, Kimchi A, Oren M. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347. http://dx.doi.org/10.1038/352345a0.
74. Fingerle-Rowson G, Petrenko O, Metz C, Forsthuber T, Mitchell R, Huss R, Moll U, Müller W, Bucala R. 2003. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354-9359. http://dx.doi.org/10.1073/pnas.1533295100.
75. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99:345-350. http://dx.doi.org/10.1073/pnas.012511599.
76. Brighenti E, Calabrese C, Liguori G, Giannone FA, Trere D, Montanaro L, Derenzini M. 2014. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene 33:4396-4406. http://dx.doi.org/10.1038/onc.2014.1.
77. Sayedyahossein S, Xu SX, Rudkouskaya A, McGavin MJ, McCormick JK, Dagnino L. 2015. Staphylococcus aureus keratinocyte invasion is mediated by integrin-linked kinase and Rac1. FASEB J 29:711-723. http://dx.doi.org/10.1096/fj.14-262774.